Sara J Coulon1, Cruz Velasco-Gonzalez2, Richard Scribner2,3, Chi L Park2,3, Ricardo Gomez4, Alfonso Vargas4, Sarah Stender4, Jovanny Zabaleta5, Patrice Clesi6, Stuart A Chalew4, James M Hempe4,6. 1. School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 2. School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 3. Department of Epidemiology, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 4. Department of Pediatrics, Louisiana State University Health Sciences Center and Children's Hospital, New Orleans, LA, USA. 5. Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA. 6. Research Institute for Children, Children's Hospital, New Orleans, LA, USA.
Abstract
BACKGROUND: Racial variation in the relationship between blood glucose and hemoglobin A1c (HbA1c) complicates diabetes diagnosis and management in racially mixed populations. Understanding why HbA1c is persistently higher in blacks than whites could help reduce racial disparity in diabetes outcomes. OBJECTIVE: Test the hypothesis that neighborhood disadvantage is associated with inflammation and poor metabolic control in a racially mixed population of pediatric type 1 diabetes patients. METHODS: Patients (n = 86, 53 white, 33 black) were recruited from diabetes clinics. Self-monitored mean blood glucose (MBG) was downloaded from patient glucose meters. Blood was collected for analysis of HbA1c and C-reactive protein (CRP). Patient addresses and census data were used to calculate a concentrated disadvantage index (CDI). High CDI reflects characteristics of disadvantaged neighborhoods. RESULTS: HbA1c and MBG were higher (p < 0.0001) in blacks [10.4% (90.3 mmol/mol), 255 mg/dL] than whites [8.9% (73.9 mmol/mol), 198 mg/dL). CDI was higher in blacks (p < 0.0001) and positively correlated with HbA1c (r = 0.40, p = 0.0002) and MBG (r = 0.35, p = 0.0011) unless controlled for race. CDI was positively associated with CRP by linear regression within racial groups. CRP was not different between racial groups, and was not correlated with MBG, but was positively correlated with HbA1c when controlled for race (p = 0.04). CONCLUSIONS: Neighborhood disadvantage was associated with inflammation and poor metabolic control in pediatric type 1 diabetes patients. Marked racial differences in potential confounding factors precluded differentiation between genetic and environmental effects. Future studies should recruit patients matched for neighborhood characteristics and treatment regimen to more comprehensively assess racial variation in HbA1c.
BACKGROUND: Racial variation in the relationship between blood glucose and hemoglobin A1c (HbA1c) complicates diabetes diagnosis and management in racially mixed populations. Understanding why HbA1c is persistently higher in blacks than whites could help reduce racial disparity in diabetes outcomes. OBJECTIVE: Test the hypothesis that neighborhood disadvantage is associated with inflammation and poor metabolic control in a racially mixed population of pediatric type 1 diabetespatients. METHODS:Patients (n = 86, 53 white, 33 black) were recruited from diabetes clinics. Self-monitored mean blood glucose (MBG) was downloaded from patientglucose meters. Blood was collected for analysis of HbA1c and C-reactive protein (CRP). Patient addresses and census data were used to calculate a concentrated disadvantage index (CDI). High CDI reflects characteristics of disadvantaged neighborhoods. RESULTS: HbA1c and MBG were higher (p < 0.0001) in blacks [10.4% (90.3 mmol/mol), 255 mg/dL] than whites [8.9% (73.9 mmol/mol), 198 mg/dL). CDI was higher in blacks (p < 0.0001) and positively correlated with HbA1c (r = 0.40, p = 0.0002) and MBG (r = 0.35, p = 0.0011) unless controlled for race. CDI was positively associated with CRP by linear regression within racial groups. CRP was not different between racial groups, and was not correlated with MBG, but was positively correlated with HbA1c when controlled for race (p = 0.04). CONCLUSIONS: Neighborhood disadvantage was associated with inflammation and poor metabolic control in pediatric type 1 diabetespatients. Marked racial differences in potential confounding factors precluded differentiation between genetic and environmental effects. Future studies should recruit patients matched for neighborhood characteristics and treatment regimen to more comprehensively assess racial variation in HbA1c.
Authors: A M Delamater; K H Shaw; E B Applegate; I A Pratt; M Eidson; G X Lancelotta; L Gonzalez-Mendoza; S Richton Journal: Diabetes Care Date: 1999-05 Impact factor: 19.112
Authors: Steven M Willi; Kellee M Miller; Linda A DiMeglio; Georgeanna J Klingensmith; Jill H Simmons; William V Tamborlane; Kristen J Nadeau; Julie M Kittelsrud; Peter Huckfeldt; Roy W Beck; Terri H Lipman Journal: Pediatrics Date: 2015-03 Impact factor: 7.124
Authors: Darrell J Gaskin; Roland J Thorpe; Emma E McGinty; Kelly Bower; Charles Rohde; J Hunter Young; Thomas A LaVeist; Lisa Dubay Journal: Am J Public Health Date: 2013-11-14 Impact factor: 9.308
Authors: Denise M Danos; Tekeda F Ferguson; Neal R Simonsen; Claudia Leonardi; Qingzhao Yu; Xiao-Cheng Wu; Richard A Scribner Journal: Ann Epidemiol Date: 2018-03-22 Impact factor: 3.797
Authors: Mona N Fouad; Gabriela R Oates; Isabel C Scarinci; Wendy Demark-Wahnefried; Bryant W Hamby; Lori B Bateman; John J Estrada; Marinelle Payton; Mario Sims; Lucio Miele; Edward E Partridge Journal: Am J Prev Med Date: 2017-01 Impact factor: 5.043
Authors: Doyle M Cummings; Shivajirao P Patil; D Leann Long; Boyi Guo; Andrea Cherrington; Monika M Safford; Suzanne E Judd; Virginia J Howard; George Howard; April P Carson Journal: Diabetes Care Date: 2021-05-06 Impact factor: 19.112
Authors: Laura M Cahill; Kiva A Fisher; William T Robinson; Kaylin J Beiter; Jovanny Zabaleta; Tung S Tseng; Maura M Kepper; Meg K Skizim; Lauren A Griffiths; Robert B Uddo; Nicole E Pelligrino; Jacob M Maronge; Kyle Happel; Richard Scribner; Melinda S Sothern Journal: Obes Sci Pract Date: 2019-10-23